Attached files

file filename
EX-99.1 - EX-99.1 - ST JUDE MEDICAL, LLCa14-17227_1ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 16, 2014

 

ST. JUDE MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

Minnesota
 (State or other jurisdiction
of incorporation)

 

1-12441

(Commission
File Number)

 

41-1276891
 (IRS Employer
Identification No.)

 

One St. Jude Medical Drive, St. Paul, MN
(Address of principal executive offices)

 

55117
(Zip Code)

 

Registrant’s telephone number, including area code: (651) 756-2000

 

Not applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 2.02                                           Results of Operations and Financial Condition.

 

On July 16, 2014, St. Jude Medical, Inc. issued a press release concerning its financial results for the second quarter 2014.  A copy of the press release is furnished as Exhibit 99.1 to this report.

 

Item 9.01                                           Financial Statements and Exhibits.

 

(d)  Exhibits:

 

99.1                                          Press release issued by St. Jude Medical, Inc. on July 16, 2014.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ST. JUDE MEDICAL, INC.

 

 

 

 

Date: July 16, 2014

 

By:

/s/ Jason Zellers

 

 

Jason Zellers

 

 

Vice President, General Counsel
and Corporate Secretary

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description of Exhibit

 

 

 

99.1

 

Press release issued by St. Jude Medical, Inc. on July 16, 2014.

 

4